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Abstract
Background: Despite being considered a non-invasive procedure, injections can cause adverse outcomes including
infections, overfilling, asymmetry, foreign body granulomas, and reactions that lead to scarring. Complications
may be associated with the procedure itself, the physician’s technique, and/or the type of agent injected. In these
instances, it is important to be able locate and identify the substance used. This study investigated the viability of
using MRI to correctly identify injected substances, their symmetry of distribution, and related complications.
Methods: Fourteen patients with suspected injectable filler complications were identified by our institution’s plastic
surgery service. All subjects were scanned with MRI, using highly specific face-oriented sequences at high resolution
with small field of view and thin slices across the axial and coronal planes by T1 Dixon non-contrast, T2 Dixon, and
T1 Dixon after gadolinium injection. Two independent and blinded radiologists evaluated the images and reported
(1) the likely injected substance, (2) symmetry, and (3) complications. These radiological results were compared
against clinical data provided by the plastic surgery service.
Results: Ten patients (83 %) presented objective injectable complications: 4 had abscess, 4 granulomata, and 2
had allergic reactions to the injected substance. The Fleiss Kappa for inter-rater agreement on substances was 0.80.
Asymmetry was identified in six patients (50 %) with a Kappa between radiology evaluators of 1. MRI characteristics
of these common fillers are summarized in table form.
Conclusions: Given the growing awareness among referring physicians of the value of dedicated facial MRI,
utilization of this imaging technique may lead to discovery of the injected substance’s true identity, evaluation of
symmetry and/or complications.
Introduction
As the use of cosmetic injectable fillers continues to rise,
so does the incidence of complications. Fillers are com-
monly administered in office settings by non-specialists
and are minimally regulated in many countries [1]. In
some cases, the identity of the substance may be un-
known or misrepresented. Despite being considered a
non-invasive procedure, injections can cause adverse
outcomes including infections, overfilling, asymmetry,
foreign body granulomas, and reactions that lead to scar-
ring [2]. Complications may be associated with the
procedure itself, the physician’s technique, and/or the
type of agent injected. In these instances, it is important
to be able locate and identify the substance used.
Background
On the molecular level, injectable fillers are designed to
last different lengths of time, and can be categorized as
short (0–3 months), medium (3–12 months), or long-
term (12 months to indefinitely) [3]. Collagen, hyalur-
onic acid, and silicone are examples of commonly used
short, medium, and long-term fillers, respectively. Gen-
erally speaking, shorter-term products have greater bio-
compatibility [4]. Depending on the type of filler used,
complication rates range from 3 % to 52 % [5]. In the
short term, adverse events can include bleeding, infec-
tions, edema, and migration. In the long term, there is a
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risk of lump formation, granulomas, abscesses, more dif-
fuse edema, and skin discoloration [2]. In these cases,
having a reliable way to identify unknown substances
prior to surgical treatment would be of great value both
medically and legally [6]. Attenuated total reflectance/
Fourier transform infrared spectroscopy can accurately
identify unknown injectable fillers [6]. However, this
method requires surgical specimen collection, which can
lead to undesirable scarring. Spectrophotometers are not
commonly found in radiology units, and their imple-
mentation requires additional cost outlays and training.
Thus clearly, a more ubiquitous and less invasive modal-
ity would be advantageous.
MRI and CT studies have documented the features of
many common injectable fillers and their related seque-
lae, and can distinguish them from normal tissues [7].
Calcium hydroxylapatite produces low-to-intermediate
signal intensity on T1 and T2 [8]. Collagen fillers are
low signal on T1 and high signal on T2. Hyaluronic acid
has a relaxation time of 600 ms on T2 [7]. Polyacryl-
amide is high intensity on T2 and low intensity on T1
[8]. Silicone is hyperintense to water on T1 and either
hypointense or isointense on T2, depending on the vis-
cosity of the specific product [9]. However, these de-
scriptions are only useful when the identity of the filler
is known and there is simply a need for visualization.
Girolamo et al. showed that granulomatous reactions to
fillers produced subcutaneous contrast enhancement
with IV gadolinium, and found that MRI could be used
to detect dermal fillers down to a minimum size of
2 mm without reliance on clinical evaluation [5].
Kadouch et al. assessed the extent of agreement between
clinical evaluations of injectable filler-related complica-
tions and an independent MRI evaluation [10], and
found good concordance in uncomplicated cases (85 %),
but not in cases with inflammation or migration (32 and
9 %, respectively).
This study investigated the feasibility of using a
dedicated imaging protocol for the assessment of all
filler-related procedures and related complications, in-
dependent of expert clinical input. We show that by
the addition of a high resolution face MRI using T1
T2 Dixon with a fat and water suppression technique,
radiologists can identify fillers in unexpected loca-
tions, and differentiate different kinds of facial fillers.
Based on the descriptions of injectable fillers [7–9],
and our own clinical experience using the T1 T2 Dixon
fat suppression (FS) technique, we also generate a refer-
ence list (Table 1) that summarizes the characteristics of
some commonly used substances on T1, T2, T1FS, and
T2FS. This table was provided to the two blinded radiol-
ogists who took part in the study, and were asked refer
to it to determine the type of injectable filler most likely
used in the cases submitted to them.
Methods
Patient population
A prospective analysis was performed on all patients
above the age of 18 who underwent dedicated face MRI
after injection of intradermal fillers at our institution
between 2013 and 2015. These patients were referred to
our imaging department from the plastic surgery depart-
ment and outpatient clinics as well as from private
esthetic clinics after complaining of asymmetry, facial
pain, or both.
MRI technique
All the patients’ faces were examined with a Siemens
Magnetom Skyra 3 Tesla MRI, using highly specific face-
oriented sequences with high resolution and a small field
of view (voxel size: 0.3*0.3*4.0 mm – 0.5*0.5*4.0 mm).
Thin slices (3–4 mm) across axial and coronal planes
were acquired using the following sequences: T1 Dixon
fast spin echo (FSE) sequence non-contrast (TR 5610.0 ms,
TE 79.0 ms, Flip angle 150 deg), with and without FS, T2
Dixon FSE non-contrast (TR 3800.0 ms, TE 103.0 ms, Flip
angle 160 deg), with and without FS, and T1 Dixon FSE
after gadolinium injection (TR 576.0 ms, TE 11 ms, Flip
angle 131 deg), with and without FS. Axial, coronal and
sagital acquisitions were used, with a total scan time of ap-
proximately 38 min.
Imaging evaluation and clinical correlation
Two independent radiologists with 30 years’ combined
experience in radiology volunteered to be evaluators,
and were blinded to the identity of substances used, the
clinical history and information related to the plastic
surgeon. They drew conclusions on the identity of the
substance, and graded complications and degree of
asymmetry (both on a scale of 1–2), based solely on
MRI imaging. When disagreements occurred they sub-
mitted their conclusions to a third party with 20 years of
experience, also blinded, who decided on likely sub-
stance identity. Kappa inter-rater tests were conducted
for substance identity, degree of complications and de-
gree of asymmetry, and compared to the surgeons’ files.
Results
Fourteen subjects who underwent MRI using the above
protocol took part in the study after signing consent
Table 1 Dermal filler characteristics on T1 weighted, T2 weighted,
T1 Fat Saturation (T1FS), T2 Fat Saturation (T2FS) sequences
Agent T1 T2 T1fs T2fs
Polyacrymallde Hypo-iso Hyper Iso-hyper Hyper
Hyaluronic Hypo Hyper Hypo Hyper
Collagen Hypo Hyper Iso-hyper Hyper
Silicone Hyper Hypo Hypo Hypo
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forms. Thirteen females (93 %) and one male (7 %) were
examined, with an average age of 46.8 years. The average
time between intradermal injection and MRI scanning
was 51 days; three patients (22 %) underwent repeat MRI
at an average time from filler to MRI of 82 days. Seven pa-
tients underwent polyacrylamide gel injection (50 %),
three hyaluronic acid (22 %), two silicone (14 %), and two
collagen (14 %). The inter-rater agreement between the
two evaluators for substance was a high 0.80 using the
Fleiss Kappa and after consensus between the two evalua-
tors, the Kappa between imaging and clinical data was
0.96 (near perfect). While polyacrylamide and hyaluronic
acid were easily identified (K = 0.86 and 0.84, respectively),
silicone and collagen showed greater disparity between
the evaluators (K = 0.77 and 0.69, respectively).
MRI detected four cases of (36 %) abscesses, four cases
(36 %) granulomata, and three (28 %) cases of allergic
reactions to injected substances. Key imaging features of
abscesses included ring enhancement after gadolinium
injection, while granulomata demonstrated diffuse signal
intensity on T1 and T2 without ring enhancement. Al-
lergic reactions were distinguished by the presence of
Fig. 1 Polyacrylamide gel axial dermal filler appearance in both infraorbital triangles (open arrows) on axial MRI (T1FS, T1 FS with gadolinium). Note the
susceptibility artifacts from dental implants (open arrowhead) while the filler’s signal intensity remains high before and after injection of gadolinium
Fig. 2 Collagen dermal filler in both infraorbital triangles (open arrows) on axial MRI (T2FS, T1, T1FS, T1FS with gadolinium)
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“patchy” signal on all sequences and fat stranding on
non fat saturated sequences around the injected sub-
stance, without enhancement after gadolinium injection.
The Kappa agreement between evaluators for the pres-
ence or absence of complications was 1.0 (perfect
agreement), and 0.76 for degree of severity. MRI visual-
ized asymmetry in (50 %) of cases and the kappa agree-
ment between evaluators on the presence or absence of
asymmetry was 1.0 and 0.72 respectively, with respect
to severity.
Discussion
These results show that facially oriented MRI with con-
trast is a reliable tool to accurately locate fillers, and
identify unintended outcomes such as migration, abscess
formation, granuloma, and delayed allergic reaction. The
use of a dedicated facial MRI with high spatial resolution
and elaborate Dixon sequences not only gives the inter-
preting radiologist the ability to make a clear-cut deci-
sion on the identity of a substance, but also provides the
referring plastic surgeon with a better understanding of
Fig. 3 Silicone dermal filler in the right infraorbital triangle (open arrow) as seen on axial MRI (T1, T1FS with gadolinium, T2FS). Note how the free
silicone oil drops behave like fat on MRI, including a intermediate to low signal on fat suppressed sequences
Fig. 4 Hyaluronic acid dermal filler in the lower infraorbital triangles (open arrows) on coronal MRI (T2FS)
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disease pathology and pathophysiology. In addition to its
clinical utility, MRI can provide forensic evidence to
medico/legal cases involving injected materials.
Although substances such as silicone and hyaluronic
acid have distinct MRI signatures because of their very
high or low water content (Fig. 1), intermediate substances
tend to produce a more ambiguous image. T1 and T2
Dixon fat suppression with high resolution small FOV
MRI make it possible to better visualize and identify these
substances (i.e., collagen, Fig. 2). Our original algorithm as
summarized in Table 1 which differentiates common
fillers in terms of their MRI characteristics, provides a
simple guide to assist radiologists in their analysis.
Dermal fillers are regulated by the Food and Drug
Administration in the US, but are only considered med-
ical devices in the UK and elsewhere [11]. Beauticians
and other unlicensed individuals can legally administer
dermal fillers [12], and the records of these procedures
may be unreliable or even nonexistent. Online vendors
sell products that may be counterfeit or expired, and
therefore of dubious quality [13]. In this risky market-
place, MRI can serve a role both medically and legally
(an example of a "dubious" injection discovered to be
silicone in Fig. 3).
For example, when a patient is unsatisfied with the re-
sult of a cosmetic injectable filling procedure, MRI could
be used to provide an objective evaluation of fullness
and symmetry. While scarring, which demonstrates a low
signal on T1 weighted images and directly impacts the
symmetry of dermal fillers, it does not hamper the correct
identification of substance or the radiologist’s ability to as-
sess the distribution of substance. If overfilling is con-
firmed (Fig. 4), and hyaluronic acid is determined to be
the culprit, a simple injection of hyaluronidase can reverse
the unwanted outcome [14]. In cases of complications in-
volving an unknown product, imaging can help to estab-
lish the identity and guide the approach to treatment.
When a granuloma arises from permanent filler (Fig. 5),
treatment may require administration of 5-fluoruracil or
allopurinol; otherwise, steroids and imiquimod may be
Fig. 5 Delayed reaction to calcium hydroxyapetite, coronal MRI (T1FS, T2FS, T1FS with gadolinium). Note the filler in the left infraorbital triangle
(open arrows), with the delayed reaction extending to the nasolabial sulcus, causing the gross asymetry
Fig. 6 Acute allergic reaction to hyaluronic acid in the left nasolabial sulcus and mouth angle sulcus region (open arrows) on coronal MRI (T2FS,
FS T1FS with gadolinium). This soft tissue reaction is often reffered to “cellulitis-like.” Note the normal filler in the right lower infraorbital triangle
and nasolabial sulcus (arrowhead)
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used [15, 16]. This further underscores the importance of
identification of the precise substance prior to initiating
therapy as regards patients’ treatment outcomes.
In the United States, “any physician who has partici-
pated in the care of a patient can be named in a lawsuit if
a case has been brought to court” [17]. Unlike in Europe,
the prevailing party in frivolous cases cannot recover any
legal costs from the losing party [17]. In order to minimize
the risk of incurring significant losses of time and money,
physicians who administer facial fillers and treat related
complications should consider using imaging to validate
procedural outcomes. It is recommended that before pro-
viding cosmetic care to a patient, all physical findings be
photographically documented [18]. MRI could be imple-
mented as an adjunct technique to evaluate asymmetry,
overfilling, and true complications, and determine whether
the use of dermal fillers has a causal relationship to any
pertinent physical findings (Fig. 6). The utility of dedicated
facial MRI should be stressed in cases of medico-legal con-
cerns, especially in light of the absence of ionizing radiation
and negligible gadolinium risk in healthy patients [19].
The main limitation of our study is sample size. There
are other types of facial filler substances on the market
than are represented in the sample, and we have not yet
had the opportunity to characterize them using our novel
MRI technique. Several non-face dedicated techniques
have been published in the literature [5, 7], and we did not
perform a randomized trial to compare our technique to
others; however, the robustness of the Dixon sequences
used, which include fat suppression and high resolution
field of view, alongside the added value of gadolinium in-
jection, serves as a precise and accurate all-encompassing
facial imaging technique. The imaging and clinical utility
of this technique was highlighted by our high inter-rater
statistics and exquisite images.
Our reference table will be updated each time we en-
counter cases of complications involving substances not
yet seen. Given the growing awareness among referring
physicians of the value of dedicated facial MRI with gado-
linium injection, we expect to see rising numbers of MRIs
performed on cases with and without complications after
cosmetic intradermal injectable filler procedures, to evalu-
ate for symmetry and help referring clinicians to provide
their post-filler patients with the best possible health and
esthetic outcomes.
Conclusion
Our research has shown that MRI can be used to deter-
mine the identity of unknown facial fillers, and to detect
complications including overfilling, asymmetry, abscesses
(Fig. 7), and granulomata. MRI imaging can help to guide
corrective treatment, to evaluate procedural outcomes,
and to provide objective evidence when legal disputes
arise. Our study size is small and non-exhaustive; we will
continue to add substances to our reference guide as we
encounter them.
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